Literature DB >> 23796245

Glaucocalyxin A and B-induced cell death is related to GSH perturbation in human leukemia HL-60 cells.

Wen Hua Yang1, Zhen Zhang, Yang Hu Sima, Jian Zhang, Jian Wen Wang.   

Abstract

Glaucocalyxin (Gla) A-C are major ent-kauranoid diterpenoids isolated from Rabdosia japonica var. glaucocalyx, a plant used in Chinese traditional medicine as an antitumor and anti-inflammatory agent. The present investigation was carried out to observe whether cellular reduced glutathione (GSH) plays important roles in Gla -induced cytotoxicity. Among major ent-kauranoid diterpenoids isolated, Gla A and B dose-dependently decreased the growth of HL-60 cells with an IC50 of approximately 6.15 and 5.86 µM at 24 h, respectively. Both Gla A and B could induce apoptosis, G2/M-phase cycle arrest, DNA damage and the accumulation of reactive oxygen species (ROS) in HL-60 cells. Moreover, Gla A, B caused rapid decrease of the intracellular GSH content, while inhibition of cellular GSH synthesis by buthionine sulfoximine (BSO) augmented the induced cytotoxicity and apoptosis in HL-60 cells. On the other hand, the administration of GSH or GSH precursor N-acetyl-cysteine (NAC) could rescue Gla A, B-depleted cellular GSH, and abrogate the induced cytotoxicity, G2/M-phase cycle arrest, DNA damage and ROS accumulation in HL-60 cells. Furthermore, Gla A, B decreased the activity of the GSH-related enzymes including glutathione reductase (GR) and glutathione peroxidase (GPX). These data suggest that the intracellular GSH redox system plays important roles in regulating the Gla A, B-induced cytotoxicity on HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796245     DOI: 10.2174/18715206113139990200

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  6 in total

1.  Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC-7721 cells.

Authors:  Lisha Tang; Xiaofeng Jin; Xiaohui Hu; Xiaoding Hu; Zulong Liu; Long Yu
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

2.  Preparation and antitumor effects of glaucocalyxin A-γ-cyclodextrin clathrate.

Authors:  Chong Zhang; Yan Qu; Yan-Long Jia; Xiao-Jun Shang; Su-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway.

Authors:  Wei Li; Xiaorong Tang; Wenxiu Yi; Qiang Li; Lijie Ren; Xiaohui Liu; Chunjun Chu; Yukio Ozaki; Jian Zhang; Li Zhu
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

4.  Glaucocalyxin A Ameliorates Myocardial Ischemia-Reperfusion Injury in Mice by Suppression of Microvascular Thrombosis.

Authors:  Xiaohui Liu; Dongzhou Xu; Yuxin Wang; Ting Chen; Qi Wang; Jian Zhang; Tao You; Li Zhu
Journal:  Med Sci Monit       Date:  2016-10-07

5.  Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway.

Authors:  Mei Li; Cailong Chen; Qian Wang; Xiaolu Jiang; Lanlan Tan; Ying Huang; Yan Zhang; Zubin Zhang
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

Review 6.  Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer ent-Kaurane Diterpenes.

Authors:  Md Shahid Sarwar; Yi-Xuan Xia; Zheng-Ming Liang; Siu Wai Tsang; Hong-Jie Zhang
Journal:  Biomolecules       Date:  2020-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.